Published in Lancet on August 16, 2012
Health financing for universal coverage and health system performance: concepts and implications for policy. Bull World Health Organ (2013) 2.26
Medicines for cancers in children: The WHO model for selection of essential medicines. Pediatr Blood Cancer (2015) 1.45
Effective coverage: a metric for monitoring Universal Health Coverage. PLoS Med (2014) 1.18
Achieving equity within universal health coverage: a narrative review of progress and resources for measuring success. Int J Equity Health (2014) 1.07
Improving women's health through universal health coverage. PLoS Med (2014) 1.06
Redesigning primary care to tackle the global epidemic of noncommunicable disease. Am J Public Health (2015) 1.04
Impact of Noncommunicable Disease Multimorbidity on Healthcare Utilisation and Out-Of-Pocket Expenditures in Middle-Income Countries: Cross Sectional Analysis. PLoS One (2015) 0.96
Evaluation of breast cancer knowledge among health promoters in Mexico before and after focused training. Oncologist (2014) 0.96
Pediatric oncology as the next global child health priority: the need for national childhood cancer strategies in low- and middle-income countries. PLoS Med (2014) 0.95
Beyond clinical skills: key capacities needed for universal health coverage. Bull World Health Organ (2013) 0.92
Strategies to increase demand for maternal health services in resource-limited settings: challenges to be addressed. BMC Public Health (2015) 0.90
Exploring the economic and social effects of care dependence in later life: protocol for the 10/66 research group INDEP study. Springerplus (2014) 0.89
Universal health coverage from multiple perspectives: a synthesis of conceptual literature and global debates. BMC Int Health Hum Rights (2015) 0.87
Impact of the Mexican government's system of social protection for health, or Seguro Popular, on pediatric oncology outcomes. Pediatr Blood Cancer (2012) 0.87
Indicators for Universal Health Coverage: can Kenya comply with the proposed post-2015 monitoring recommendations? Int J Equity Health (2014) 0.86
A comprehensive approach to women's health: lessons from the Mexican health reform. BMC Womens Health (2012) 0.86
Evaluating a health care provider delivered intervention to reduce intimate partner violence and mitigate associated health risks: study protocol for a randomized controlled trial in Mexico City. BMC Public Health (2014) 0.84
The impact of increasing health insurance coverage on disparities in mortality: health care reform in Colombia, 1998-2007. Am J Public Health (2013) 0.83
Contribution of socioeconomic factors and health care access to the awareness and treatment of diabetes and hypertension among older Mexican adults. Salud Publica Mex (2015) 0.83
Service, training, mentorship: first report of an innovative education-support program to revitalize primary care social service in Chiapas, Mexico. Glob Health Action (2014) 0.83
The Mexican experience in monitoring and evaluation of public policies addressing social determinants of health. Glob Health Action (2016) 0.81
Descriptive Epidemiology in Mexican children with cancer under an open national public health insurance program. BMC Cancer (2014) 0.80
A new entity for the negotiation of public procurement prices for patented medicines in Mexico. Bull World Health Organ (2012) 0.80
Commentary: Mexico: moving from universal health coverage towards health care for all. Glob Public Health (2015) 0.79
Changes in socioeconomic inequality in Indonesian children's cognitive function from 2000 to 2007: a decomposition analysis. PLoS One (2013) 0.78
The effect of obesity on incidence of disability and mortality in Mexicans aged 50 years and older. Salud Publica Mex (2015) 0.78
The economic status of older people's households in urban and rural settings in Peru, Mexico and China: a 10/66 INDEP study cross-sectional survey. Springerplus (2016) 0.78
Sleeping money: investigating the huge surpluses of social health insurance in China. Int J Health Care Finance Econ (2013) 0.77
Return Migration to Mexico: Does Health Matter? Demography (2015) 0.77
Prospective study of the link between overweight/obesity and diabetes incidence among Mexican older adults: 2001-2012. Salud Publica Mex (2015) 0.77
The challenge of cancer in middle-income countries with an ageing population: Mexico as a case study. Ecancermedicalscience (2015) 0.76
The burden of blood-pressure-related cardiovascular mortality in Mexico. Int J Hypertens (2014) 0.76
Voluntary Health Insurance expenditure in low- and middle-income countries: Exploring trends during 1995-2012 and policy implications for progress towards universal health coverage. Int J Equity Health (2016) 0.75
Assessment of universal health coverage for adults aged 50 years or older with chronic illness in six middle-income countries. Bull World Health Organ (2016) 0.75
Primary health care utilization by the mexican indigenous population: the role of the Seguro popular in socially inequitable contexts. PLoS One (2014) 0.75
An ecological study of stillbirths in Mexico from 2000 to 2013. Bull World Health Organ (2016) 0.75
Implementation science in cancer prevention and control: a framework for research and programs in low- and middle-income countries. Cancer Epidemiol Biomarkers Prev (2014) 0.75
Preventive health screening utilization in older Mexicans before and after healthcare reform. Salud Publica Mex (2015) 0.75
Understanding the dynamics of the Seguro Popular de Salud policy implementation in Mexico from a complex adaptive systems perspective. Implement Sci (2016) 0.75
Comparison of medicines management strategies in insurance schemes in middle-income countries: four case studies. J Pharm Policy Pract (2017) 0.75
Access to care issues adversely affect breast cancer patients in Mexico: oncologists' perspective. BMC Cancer (2014) 0.75
Inequalities in financial risk protection in Bangladesh: an assessment of universal health coverage. Int J Equity Health (2017) 0.75
A Modified Behavior Risk Factor Surveillance System to Assess Diabetes Self-management Behaviors and Diabetes Care in Monterrey Mexico: A Cross-sectional Study. Front Public Health (2017) 0.75
Prioritization of strategies to approach the judicialization of health in Latin America and the Caribbean. Rev Saude Publica (2016) 0.75
Mexico's path towards the Sustainable Development Goal for health: an assessment of the feasibility of reducing premature mortality by 40% by 2030. Lancet Glob Health (2016) 0.75
A Performance Analysis of Public Expenditure on Maternal Health in Mexico. PLoS One (2016) 0.75
Report from a symposium on catalyzing primary and secondary prevention of cancer in India. Cancer Causes Control (2015) 0.75
Implications of Mexican Health Care Reform on the Health Coverage of Nonmigrants and Returning Migrants. Am J Public Health (2016) 0.75
Factors behind job preferences of Peruvian medical, nursing and midwifery students: a qualitative study focused on rural deployment. Hum Resour Health (2015) 0.75
Abortion legislation, maternal healthcare, fertility, female literacy, sanitation, violence against women and maternal deaths: a natural experiment in 32 Mexican states. BMJ Open (2015) 0.75
CD4 Counts at Entry to HIV Care in Mexico for Patients under the "Universal Antiretroviral Treatment Program for the Uninsured Population," 2007-2014. PLoS One (2016) 0.75
Building from the HIV Response toward Universal Health Coverage. PLoS Med (2016) 0.75
Self-Reported Health and Functional Characteristics of Mexican and Mexican American Adults Aged 80 and Over. J Aging Health (2016) 0.75
State budget transfers to Health Insurance to expand coverage to people outside formal sector work in Latin America. BMC Health Serv Res (2017) 0.75
Access to Medicines by Seguro Popular Beneficiaries: Pending Tasks towards Universal Health Coverage. PLoS One (2015) 0.75
Financing Maternal Health and Family Planning: Are We on the Right Track? Evidence from the Reproductive Health Subaccounts in Mexico, 2003-2012. PLoS One (2016) 0.75
Effects of the expansion of doctors' offices adjacent to private pharmacies in Mexico: secondary data analysis of a national survey. BMJ Open (2014) 0.75
Health Insecurity and Social Protection: Pathways, Gaps, and Their Implications on Health Outcomes and Poverty. Int J Health Policy Manag (2015) 0.75
The economic burden of overseas medical treatment: a cross sectional study of Maldivian medical travelers. BMC Health Serv Res (2015) 0.75
Global methylation and promoter-specific methylation of the P16, SOCS-1, E-cadherin, P73 and SHP-1 genes and their expression in patients with multiple myeloma during active disease and remission. Exp Ther Med (2017) 0.75
Strengthening Health Systems of Developing Countries: Inclusion of Surgery in Universal Health Coverage. World J Surg (2015) 0.75
Global health 2035: a world converging within a generation. Lancet (2013) 16.85
Expansion of cancer care and control in countries of low and middle income: a call to action. Lancet (2010) 6.84
AIDS in Mexico: lessons learned and implications for developing countries. AIDS (2002) 4.48
Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis. Cell Metab (2006) 3.95
Improvement of child survival in Mexico: the diagonal approach. Lancet (2006) 3.87
The Global Campaign for the Health MDGs: challenges, opportunities, and the imperative of shared learning. Lancet (2007) 3.86
Assessing the effect of the 2001-06 Mexican health reform: an interim report card. Lancet (2006) 3.33
Comprehensive reform to improve health system performance in Mexico. Lancet (2006) 3.27
Variant in PNPLA3 is associated with alcoholic liver disease. Nat Genet (2009) 3.24
Evidence is good for your health system: policy reform to remedy catastrophic and impoverishing health spending in Mexico. Lancet (2006) 3.20
Matching strategies for genetic association studies in structured populations. Am J Hum Genet (2004) 3.13
Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial. Lancet (2011) 3.12
Determinants of prevalence, acquisition, and persistence of human papillomavirus in healthy Mexican military men. Cancer Epidemiol Biomarkers Prev (2005) 2.86
Evidence-based health policy: three generations of reform in Mexico. Lancet (2003) 2.64
Health metrics and evaluation: strengthening the science. Lancet (2008) 2.55
Fetal lead exposure at each stage of pregnancy as a predictor of infant mental development. Environ Health Perspect (2006) 2.31
Associations of early childhood manganese and lead coexposure with neurodevelopment. Environ Health Perspect (2011) 2.31
Antioxidant supplementation and lung functions among children with asthma exposed to high levels of air pollutants. Am J Respir Crit Care Med (2002) 2.22
Nutrition transition in Mexico and in other Latin American countries. Nutr Rev (2004) 2.22
Health insurance in Mexico: achieving universal coverage through structural reform. Health Aff (Millwood) (2005) 2.22
Longitudinal associations between blood lead concentrations lower than 10 microg/dL and neurobehavioral development in environmentally exposed children in Mexico City. Pediatrics (2006) 2.17
Education of health professionals for the 21st century: a global independent Commission. Lancet (2010) 2.10
Ranking 37th--measuring the performance of the U.S. health care system. N Engl J Med (2010) 2.07
Estimating the impact of different cigarette package warning label policies: the auction method. Addict Behav (2007) 1.82
The Lancet-University of Oslo Commission on Global Governance for Health, in collaboration with the Harvard Global Health Institute. Lancet (2011) 1.78
Prevalence and determinants of human papillomavirus infection in men attending vasectomy clinics in Mexico. Int J Cancer (2006) 1.75
Influence of prenatal lead exposure on genomic methylation of cord blood DNA. Environ Health Perspect (2009) 1.74
Are women and providers satisfied with antenatal care? Views on a standard and a simplified, evidence-based model of care in four developing countries. BMC Womens Health (2002) 1.59
Early postnatal blood manganese levels and children's neurodevelopment. Epidemiology (2010) 1.58
Targeting cholesterol at different levels in the mevalonate pathway protects fatty liver against ischemia-reperfusion injury. J Hepatol (2010) 1.51
Priority setting for health interventions in Mexico's System of Social Protection in Health. Lancet (2006) 1.49
Globalization and the challenges to health systems. Health Aff (Millwood) (2002) 1.45
Maternal lead exposure and the secondary sex ratio. Hum Reprod (2006) 1.44
[Guideline for interpretation and report of the antibody to hepatitis C virus. Grupo de Desarrollo de la Guía ]. Rev Invest Clin (2013) 1.42
Addressing inequity in health and health care in Mexico. Health Aff (Millwood) (2002) 1.41
Impact of bone lead and bone resorption on plasma and whole blood lead levels during pregnancy. Am J Epidemiol (2004) 1.40
Effect of calcium supplementation on blood lead levels in pregnancy: a randomized placebo-controlled trial. Environ Health Perspect (2008) 1.37
Reliability and determinants of anogenital distance and penis dimensions in male newborns from Chiapas, Mexico. Paediatr Perinat Epidemiol (2007) 1.36
Intervention strategies to reduce the burden of non-communicable diseases in Mexico: cost effectiveness analysis. BMJ (2012) 1.31
Ideas and ideals: ethical basis of health reform in Mexico. Lancet (2009) 1.28
Globalisation and the challenges to health systems. BMJ (2002) 1.27
In utero exposure to the antiandrogen 1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene (DDE) in relation to anogenital distance in male newborns from Chiapas, México. Am J Epidemiol (2007) 1.26
[The health system of Peru]. Salud Publica Mex (2011) 1.24
Effect of breast milk lead on infant blood lead levels at 1 month of age. Environ Health Perspect (2004) 1.23
Breast cancer in Mexico: a pressing priority. Reprod Health Matters (2008) 1.20
Innovative financing for health: what is truly innovative? Lancet (2012) 1.19
Meeting the emerging challenge of breast and cervical cancer in low- and middle-income countries. Int J Gynaecol Obstet (2012) 1.18
Peak bone mineral area density and determinants among females aged 9 to 24 years in Mexico. Osteoporos Int (2003) 1.17
The democratization of health in Mexico: financial innovations for universal coverage. Bull World Health Organ (2009) 1.16
Cervical cancer, a disease of poverty: mortality differences between urban and rural areas in Mexico. Salud Publica Mex (2003) 1.14
Variants in iron metabolism genes predict higher blood lead levels in young children. Environ Health Perspect (2008) 1.14
Household catastrophic health expenditures: a comparative analysis of twelve Latin American and Caribbean Countries. Salud Publica Mex (2011) 1.13
[Analysis of the impact of cigarette pack graphic warnings on Mexican smokers]. Salud Publica Mex (2006) 1.13
[The health system of Mexico]. Salud Publica Mex (2011) 1.12
High prevalence of metabolic syndrome in Mexico. Arch Med Res (2004) 1.10
Strengthening the quality agenda in health care in low- and middle-income countries: questions to consider. Int J Qual Health Care (2012) 1.10
[Tobacco use in Mexican households: results of the Income and Expenses Survey of Households, 1984-2000]. Salud Publica Mex (2002) 1.09
[Comprehensive reform to improve health system performance in Mexico]. Salud Publica Mex (2007) 1.08
Associations of iron metabolism genes with blood manganese levels: a population-based study with validation data from animal models. Environ Health (2011) 1.06
Maternal self-esteem, exposure to lead, and child neurodevelopment. Neurotoxicology (2007) 1.05
Prenatal exposure to the major DDT metabolite 1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene (DDE) and growth in boys from Mexico. Environ Res (2010) 1.04
Redesigning primary care to tackle the global epidemic of noncommunicable disease. Am J Public Health (2015) 1.04
Mechanism of mitochondrial glutathione-dependent hepatocellular susceptibility to TNF despite NF-kappaB activation. Gastroenterology (2008) 1.04
[Public policies for the detection of breast cancer in Mexico]. Salud Publica Mex (2009) 1.03
Modifications in the human T cell proteome induced by intracellular HIV-1 Tat protein expression. Proteomics (2006) 1.03
Impact of breastfeeding on the mobilization of lead from bone. Am J Epidemiol (2002) 1.02
[The health care costs of breast cancer: the case of the Mexican Social Security Institute]. Salud Publica Mex (2009) 1.02
Prevalence and determinants of male partner violence against Mexican women: a population-based study. Salud Publica Mex (2004) 1.02
Prenatal lead exposure and weight of 0- to 5-year-old children in Mexico city. Environ Health Perspect (2011) 1.01
Maternal blood, plasma, and breast milk lead: lactational transfer and contribution to infant exposure. Environ Health Perspect (2013) 1.01
The growing movement for universal health coverage. Lancet (2011) 1.01
Improving global health education: development of a Global Health Competency Model. Am J Trop Med Hyg (2014) 1.01
Biological markers of fetal lead exposure at each stage of pregnancy. J Toxicol Environ Health A (2006) 1.00
Keeping promises for women and children. Lancet (2012) 0.99
Prevalence and characteristics of early-onset type 2 diabetes in Mexico. Am J Med (2002) 0.99
[Catastrophic health expenditures in Mexico: magnitude, distribution and determinants]. Salud Publica Mex (2005) 0.99
Influence of maternal bone lead burden and calcium intake on levels of lead in breast milk over the course of lactation. Am J Epidemiol (2005) 0.98
[Chronic non-communicable diseases in Mexico: epidemiologic synopsis and integral prevention]. Salud Publica Mex (2008) 0.98
Proceed with caution: peginterferon alpha-2a versus peginterferon alfa-2b in chronic hepatitis C. A systematic review of randomized trials. Hepatology (2010) 0.98
[Towards a National Universal Health System]. Cir Cir (2015) 0.97
[Financial protection in health: Mexico, 1992 to 2004]. Salud Publica Mex (2006) 0.97
Amebic liver abscess. Ann Hepatol (2004) 0.96
GBD 2.0: a continuously updated global resource. Lancet (2013) 0.96
[Factors associated with physical activity among Mexican women of childbearing age]. Rev Panam Salud Publica (2003) 0.96
Acetaldehyde-induced mitochondrial dysfunction sensitizes hepatocytes to oxidative damage. Cell Biol Toxicol (2009) 0.95
[Fair health financing and catastrophic health expenditures: potential impact of the coverage extension of the popular health insurance in Mexico]. Salud Publica Mex (2005) 0.95
[Trends of tobacco demand in Mexico: 1992-1998]. Salud Publica Mex (2002) 0.95
Relationship of blood and bone lead to menopause and bone mineral density among middle-age women in Mexico City. Environ Health Perspect (2003) 0.95
Th2-associated alternative Kupffer cell activation promotes liver fibrosis without inducing local inflammation. Int J Biol Sci (2011) 0.94
Oseltamivir-resistant pandemic (H1N1) 2009 virus, Mexico. Emerg Infect Dis (2011) 0.94
[Affection, kisses, and condoms: the ABC of sexual practices of female sex workers in Mexico City]. Salud Publica Mex (2003) 0.94
Health-related quality of life and depression in patients with chronic hepatitis C. Arch Med Res (2003) 0.94
Reliability of reported breastfeeding duration among reproductive-aged women from Mexico. Matern Child Nutr (2009) 0.94
[Breast cancer in Mexico: an urgent priority]. Salud Publica Mex (2009) 0.93